Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study ; volume:13 ; number:1 ; day:20 ; month:3 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (20.3.2023), 1-10, 12.2023
- Urheber
-
Moon, Jayoung
Lee, Jeong Hoon
Roh, Jin
Lee, Da Hyun
Ha, Eun Ju
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-31212-8
- URN
-
urn:nbn:de:101:1-2023080821083510977472
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moon, Jayoung
- Lee, Jeong Hoon
- Roh, Jin
- Lee, Da Hyun
- Ha, Eun Ju
- SpringerLink (Online service)
Ähnliche Objekte (12)
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Differentiated thyroid carcinoma in elderly patients (over 70 years)
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
Pediatric Differentiated Thyroid Carcinoma Risk Factor For Analysis For Disease Free Survival
Differentiated thyroid carcinoma in children: Clinical characteristics and long-term follow-up
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Differentiated thyroid carcinoma in elderly patients (over 70 years)
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
Pediatric Differentiated Thyroid Carcinoma Risk Factor For Analysis For Disease Free Survival
Differentiated thyroid carcinoma in children: Clinical characteristics and long-term follow-up
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Differentiated thyroid carcinoma in elderly patients (over 70 years)
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
Pediatric Differentiated Thyroid Carcinoma Risk Factor For Analysis For Disease Free Survival